Surgepays is trading 5.2% down at $0.18, with recent financial disclosures continuing to weigh on sentiment; no new company-specific catalyst was identified for August 26, 2026.
- The broader market is nearly flat, making overall sentiment an unlikely primary explanation.
- The company reported $1.95 million in cash and a $21.3 million working-capital deficit.
- It disclosed substantial doubt about meeting obligations over the next 12 months.